Evidence map›Paper›PMID 35962425›Full record

ArticleBMC public health2022

Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season.

Brooke M Ramay, Jorge Jara, Maria Purificación Moreno, Patrizia Lupo, Carlos Serrano, Juan P Alvis, C Sofia Arriola, Vic Veguilla, S Cornelia Kaydos-Daniels

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Brooke M RamayProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala. bramay@uvg.edu.gt.
Jorge JaraProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala.
Maria Purificación MorenoProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala.
Patrizia LupoProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala.
Carlos SerranoProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala.
Juan P AlvisProgram for Influenza and Other Respiratory Viruses, Center for Health Studies, Research Institute, Universidad del Valle de Guatemala (UVG), Guatemala City, Guatemala.
C Sofia ArriolaU.S. Centers for Disease Control and Prevention (CDC), Atlanta, USA.
Vic VeguillaU.S. Centers for Disease Control and Prevention (CDC), Atlanta, USA.
S Cornelia Kaydos-DanielsU.S. Centers for Disease Control and Prevention (CDC), Atlanta, USA.
Universidad del Valle de Guatemala · GTCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to characterize the proportion of clients presenting to community pharmacies with influenza-like illness (ILI) and the severity of their illness; the proportion with detectable influenza A, influenza B, and other pathogens (i.e., parainfluenza I, II, and III, adenovirus, respiratory syncytial virus, human metapneumovirus); and to describe their self-medication practices.

methodsA cross-sectional study was conducted in six pharmacies in Guatemala City. Study personnel collected nasopharyngeal and oropharyngeal swabs from participants who met the ILI case definition and who were self-medicating for the current episode. Participants were tested for influenza A and B and other pathogens using real-time RT-PCR. Participants' ILI-associated self-medication practices were documented using a questionnaire.

resultsOf all patients entering the pharmacy during peak hours who responded to a screening survey (n = 18,016) 6% (n = 1029) self-reported ILI symptoms, of which 45% (n = 470/1029) met the study case definition of ILI. Thirty-one percent (148/470) met inclusion criteria, of which 87% (130/148) accepted participation and were enrolled in the study. Among 130 participants, nearly half tested positive for viral infection (n = 55, 42.3%) and belonged to groups at low risk for complications from influenza. The prevalence of influenza A was 29% (n = 35). Thirteen percent of the study population (n = 17) tested positive for a respiratory virus other than influenza. Sixty-four percent of participants (n = 83) reported interest in receiving influenza vaccination if it were to become available in the pharmacy. Medications purchased included symptom-relieving multi-ingredient cold medications (n = 43/100, 43%), nonsteroidal anti-inflammatory drugs (n = 23, 23%), and antibiotics (n = 16, 16%). Antibiotic use was essentially equal among antibiotic users regardless of viral status. The broad-spectrum antibiotics ceftriaxone and azithromycin were the most common antibiotics purchased.

conclusionsDuring a typical influenza season, a relatively low proportion of all pharmacy visitors were experiencing influenza symptoms. A high proportion of clients presenting to pharmacies with ILI tested positive for a respiratory virus. Programs that guide appropriate use of antibiotics in this population are needed and become increasingly important during pandemics caused by respiratory viral pathogens.

Indexed as

Influenza, HumanPharmaciesVirus DiseasesAnti-Bacterial AgentsCross-Sectional StudiesGuatemalaHumansSeasonsAnti-Bacterial AgentsAntibioticsInfluenza Like IllnessPharmacy based study

Identifiers

PMID35962425
PMCPMC9374570
OpenAlexW4291109821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.